|
作者: Mayer, AMS (Mayer, Alejandro M. S.)[ 1 ] ; Glaser, KB (Glaser, Keith B.)[ 1,2 ] ; Cuevas, C (Cuevas, Carmen)[ 3 ] ; Jacobs, RS (Jacobs, Robert S.); Kem, W (Kem, William)[ 5 ] ; |
|
来源出版物: |
| 摘要: The global marine pharmaceutical pipeline consists of three Food and Drug Administration (FDA) approved drugs, one EU registered drug, 13 natural products (or derivatives thereof) in different phases of the clinical pipeline and a large number of marine chemicals in the preclinical pipeline. In the United States there are three FDA approved marine-derived drugs, namely cytarabine (Cytosar-U (R), Depocyt (R)), vidarabine (Vira-A (R)) and ziconotide (Prialt (R)). The current clinical pipeline includes 13 marine-derived compounds that are either in Phase I, Phase II or Phase III clinical trials. Several key Phase III studies are ongoing and there are seven marine-derived compounds now in Phase II trials. The preclinical pipeline continues to supply several hundred novel marine compounds every year and those continue to feed the clinical pipeline with potentially valuable compounds. From a global perspective the marine pharmaceutical pipeline remains very active, and now has sufficient momentum to deliver several additional compounds to the marketplace in the near future; this review provides a current view of the pipeline. |





![]() |
The odyssey of marine pharmaceuticals: a current pipeline perspective |
真菌的分布很广,有一部分可寄生在动物和植物体上引起真菌病害。在植物病害中,真菌病害的数量最多。作物上常见的病害如黑粉病,锈...
来源于 《中国药典》2010版 《中国药品检验标准操作规范》 1乙二胺四醋酸二钠滴定液(0.05mol/L) 2乙醇制氢氧化钾滴定液(0.5mol/L或0.1mol/...
...
采用合适的培养基对成功分离和正确鉴定疫霉菌十分重要。许多疫霉菌的生长和产孢对培养基成份有特定的要求,例如一些疫霉菌在用于真...